PMAS
ABMD

PNC Managed Account Solutions’s Abiomed Inc ABMD Stock Holding History

PNC Managed Account Solutions’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$27K Buy
+88
New +$27K 0.01% 419

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

PNC Managed Account Solutions's ABMD Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in Abiomed Inc (ABMD) in Q2 2021: 88 shares worth $27K. The stake represents 0.01% of the portfolio and ranks #419 among its holdings.

474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • PNC Managed Account Solutions held 88 shares of Abiomed Inc worth $27K as of Q2 2021.
  • Abiomed Inc was a new PNC Managed Account Solutions position in Q2 2021.
  • Abiomed Inc made up 0.01% of PNC Managed Account Solutions's portfolio in Q2 2021, its #419 holding.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.